The present study offers further substantiation of the effects of SGLT2 on mortality and provides new evidence of its effects on ACS, arrhythmia, UTI, kidney injury, hypoglycemia, sepsis and other indices (40). This evidence concerns the gene SLC5A2 and Hypoglycemia.